Telix Pharmaceuticals (TLX1N) Revenue
Telix Pharmaceuticals Revenue
Telix Pharmaceuticals had a revenue of 467.85M in the quarter ending Jun 30, 2026, with 12.20%. This bring the company's revenue in the last twelve months to 884.82M, Increased 14.60%. In the fiscal year ending Dec 31, 2025, Telix Pharmaceuticals had annual revenue of 816.72M with 4.28% growth.
- Revenue (ttm)
- 884.82M
- Revenue Growth
- 21.03%
- P/S Ratio
- 72.24
- Revenue/Employee
- MXN 708,955
- Employees
- 1,152
- Market Cap
- MXN 59.00B
Revenue Chart
Telix Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.72M | 33.51M | 4.28% |
| Dec 31, 2024 | 783.21M | 280.66M | 55.85% |
| Dec 31, 2023 | 502.55M | 342.45M | 213.90% |
| Dec 31, 2022 | 160.10M | 152.50M | 2007.64% |
| Dec 31, 2021 | 7.60M | 2.38M | 45.71% |
| Dec 31, 2020 | 5.21M | 1.73M | 49.58% |
| Dec 31, 2019 | 3.48M | 3.29M | 1685.88% |
| Dec 31, 2018 | 195.14K | 195.14K | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| MX:TLX1N | 884.82M |